MARKET

DWTX

DWTX

Dogwood Therapeutics
NASDAQ
6.01
-0.13
-2.12%
After Hours: 5.92 -0.09 -1.50% 16:50 12/05 EST
OPEN
6.09
PREV CLOSE
6.14
HIGH
6.15
LOW
6.00
VOLUME
36.16K
TURNOVER
--
52 WEEK HIGH
29.28
52 WEEK LOW
1.870
MARKET CAP
178.66M
P/E (TTM)
-0.2411
1D
5D
1M
3M
1Y
5Y
1D
Dogwood files for IP protection for synthetic Halneuron
TipRanks · 4d ago
Dogwood Therapeutics Files For New Intellectual Property Protection For Synthetic Halneuron
Benzinga · 4d ago
Weekly Report: what happened at DWTX last week (1124-1128)?
Weekly Report · 6d ago
Dogwood Therapeutics Launches $8.56M At-The-Market Stock Offering Under New Equity Distribution Agreement
Benzinga · 11/28 19:52
DOGWOOD THERAPEUTICS INC - TO SELL SHARES WORTH UP TO $8.56 MLN - SEC FILING
Reuters · 11/28 19:19
Weekly Report: what happened at DWTX last week (1117-1121)?
Weekly Report · 11/24 09:26
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
TipRanks · 11/21 18:28
Dogwood Therapeutics Inc. held special shareholder meeting
Reuters · 11/21 18:02
More
About DWTX
Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).

Webull offers Dogwood Therapeutics Inc stock information, including NASDAQ: DWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DWTX stock methods without spending real money on the virtual paper trading platform.